11/20
08:15 am
tecx
Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
Medium
Report
Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
11/13
02:07 am
tecx
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
Low
Report
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
11/12
09:43 am
tecx
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
Medium
Report
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
11/11
05:40 pm
tecx
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Leerink Partners from $49.00 to $69.00. They now have an "outperform" rating on the stock.
Medium
Report
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Leerink Partners from $49.00 to $69.00. They now have an "outperform" rating on the stock.
11/11
05:00 am
tecx
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
Low
Report
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
11/7
04:18 pm
tecx
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/7
04:01 pm
tecx
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
Medium
Report
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
10/27
11:23 am
tecx
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock [Yahoo! Finance]
Low
Report
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock [Yahoo! Finance]
10/25
12:22 am
tecx
GPCR drugmaker Septerna amasses $288M in IPO [Yahoo! Finance]
Low
Report
GPCR drugmaker Septerna amasses $288M in IPO [Yahoo! Finance]
10/22
04:01 pm
tecx
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Medium
Report
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
10/20
06:04 am
tecx
Tectonic Therapeutic: Interesting CV Disease Drug Developer [Seeking Alpha]
Low
Report
Tectonic Therapeutic: Interesting CV Disease Drug Developer [Seeking Alpha]
9/23
10:29 am
tecx
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Medium
Report
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
9/20
07:32 am
tecx
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 [Yahoo! Finance]
Low
Report
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 [Yahoo! Finance]
9/19
04:01 pm
tecx
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
Low
Report
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45